Company Profile

SUVEN PHARMACEUTICALS LTD.

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE384.0016.1 (+4.38 % )
PREV CLOSE (Rs.) 367.90
OPEN PRICE (Rs.) 372.50
BID PRICE (QTY) 383.50 (8 )
OFFER PRICE (QTY) 384.60 (61 )
VOLUME 21621
TODAY'S LOW / HIGH (Rs.)355.50 389.70
52 WK LOW / HIGH (Rs.)87.05 416.2
NSE387.35 18.85 (+5.12 % )
PREV CLOSE(Rs.) 368.50
OPEN PRICE (Rs.) 368.50
BID PRICE (QTY) 387.45 (2 )
OFFER PRICE (QTY) 388.00 (837 )
VOLUME 499088
TODAY'S LOW / HIGH(Rs.) 365.20 389.00
52 WK LOW / HIGH (Rs.)87.6 420

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.66
TTM EPS (Rs.) 9.89
P/E Ratio 38.20
Book Value (Rs.) 36.49
Face Value (Rs.) 1
MCap (Rs. in Mn) 96187.37
Price/Earning (TTM) 34.47
Price/Sales (TTM) 11.46
Price/Book (MRQ) 10.35
PAT Margin (%) 32.39
ROCE (%) 46.23
Incorporation Year : 2018

Management Info :

Venkateswarlu Jasti - Chairman Venkateswarlu Jasti - Managing Director

Registered Office :

Address : #8-2-334 I, S D E Serene Chambers,6th Floor Road No. 5,Avenue 7, Banjara Hills ,
Hyderabad,
Telangana-500034

Phone : 040 - 2354 9414/ 3311/ 3315

Website : www.suvenpharm.com

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
31Oct10-31-2020$Suven Suven Pharmaceuticals informs about press release Suven Suven Pharmaceuticals
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Suven Pharmaceuticals has informed that it has enclosed the copies of the newspaper advertisements regarding to Financial Results of the Company for the quarter and half-year ended September 30, 2020. The advertisements as appeared on October 31, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements.

The above information is a part of company’s filings submitted to BSE. 
Pursuant to Regulation 47 of the SEBI (Listing Obligations and..
07Jul07-07-2020$Suven Pharmaceuticals informs about confirmation certificate Suven Pharmaceuticals inform

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, Suven Pharmaceuticals has informed that it has enclosed the Confirmation Certificate issued by KFin Technologies, Registrar and Share Transfer Agents of the Company, for the quarter ended June 30, 2020.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 74(5) of SEBI (Depositories and Particip..
Financials More
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit653.312700.8
Gross Profit 880.88 3575.9
Operating Profit 988.514032.63
Net Sales 2373.888337.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 6557.00 (3.19%)
M.Cap ( in Cr)
10874.75
Neuland Laboratories (BSE)
 1038.00 (3.81%)
M.Cap ( in Cr)
1318.34
JB Chem & Pharma (BSE)
 989.15 (3.87%)
M.Cap ( in Cr)
7659.43
Abbott India (BSE)
 15400.35 (0.24%)
M.Cap ( in Cr)
32704.16
Alkem Laboratories (BSE)
 2850.00 (1.13%)
M.Cap ( in Cr)
34057.49
Shareholding Pattern More
PROMOTERS 60 %
NON-INSTITUTION 30.86 %
MUTUAL FUNDS/UTI 3.54 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes